Global Transcatheter Aortic Valve Implantation Market (2021-2030): Key Market Players include Edward Lifesciences, Boston Scientific and Medtronic Plc Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Transcatheter Aortic Valve Implantation Market by Procedure: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

The global transcatheter aortic valve implantation market was valued at $4,559 million in 2020, and is estimated to reach $16,937 million by 2030, growing at a CAGR of 14.0% from 2021 to 2030.

Transcatheter aortic valve implantation (TAVI), also called as transcatheter aortic valve replacement (TAVR), is a minimally invasive surgical procedure, which is performed to treat high-risk patients suffering from aortic stenosis. This aortic valve replacement can be performed with open heart surgery. Aortic stenosis is a condition where aortic valve cannot open and close properly, this condition can result in breathlessness, chest pain, dizziness, and swollen ankles. And in transcatheter aortic valve implantation an aortic valve to be implanted using a long narrow tube called a catheter. TAVI is more convenient for people who are frail to have a conventional valve replacement. TAVI involves implantation of transcatheter aortic valves to regenerate the blood circulation ability of the aortic valve. The need of transcatheter aortic valve implantation is on the rise, due to the increase in prevalence of aortic stenosis.

The growth of the global transcatheter aortic valve implantation (TAVI) market is majorly driven by alarming increase in the prevalence of aortic stenosis, a rise in the geriatric population, advancements in transcatheter aortic valves and increase in adoption rate of TAVI devices drive the market. However, stringent government regulations for approval of transcatheter aortic valves, which are class III medical devices and high cost associated with TAVI hamper the market growth. Conversely, use of TAVI systems for new indications, rise in healthcare expenditure in emerging economies, and increase in interest of key players in the TAVI market are projected to provide several growth opportunities for the market throughout the forecast period.

KEY BENEFITS FOR STAKEHOLDERS

• The report provides an in-depth analysis of the global transcatheter aortic valve implantation market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis of the region assists to understand the regional market and facilitating strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global transcatheter aortic valve implantation market.

KEY MARKET SEGMENTS

By Procedure

• Transfemoral Procedure
• Subclavian Procedure
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Switzerland
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Israel
• Saudi Arabia
• South Africa
• Rest of LAMEA

KEY MARKET PLAYERS

• Abbott Laboratories
• Boston Scientific Corporation
• Blue Sail Medical Co.Ltd.
• Bracco
• Edward Lifesciences
• JC Medical Inc.
• JenaValve Techologies Inc.
• Medtronic Plc
• Meril Lifesciences
• Venus Medtech

Key Topics Covered:

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.2. CXO perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market definition and scope

3.2. Key findings

3.3. Porter's five forces analysis

3.4. Top player positioning, 2020

3.5. Market dynamics

3.6. Impact analysis of COVID-19 on the TAVI market

CHAPTER 4: MINIMALLY INVASIVE SURGERY MARKET, BY PROCEDURE

4.1. Overview

4.1.1. Market size and forecast

4.2. Transfemoral Procedure

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast, by region

4.3. Subclavian Procedure

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast, by region

4.4. Others

4.4.1. Key market trends and growth opportunities

4.4.2. Market size and forecast, by region

CHAPTER 5: TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY REGION

5.1. Overview

5.1.1. Market size and forecast, by region

5.2. North America

5.2.1. Key market trends, growth factors, and opportunities

5.2.2. North America transcatheter aortic valve implantation market, by procedure

5.2.3. Market size and forecast, by country

5.3. Europe

5.3.1. Key market trends, growth factors, and opportunities

5.3.2. Europe transcatheter aortic valve implantation market, by procedure

5.3.3. Market size and forecast, by country

5.4. Asia-Pacific

5.4.1. Key market trends, growth factors, and opportunities

5.4.2. Asia-Pacific transcatheter aortic valve implantation market, by procedure

5.4.3. Market size and forecast, by country

5.5. LAMEA

5.5.1. Key market trends, growth factors, and opportunities

5.5.2. LAMEA transcatheter aortic valve implantation market, by procedure

5.5.3. Market size and forecast, by country

CHAPTER 6: COMPANY PROFILES: TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET

For more information about this report visit https://www.researchandmarkets.com/r/r4a5mk

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900